HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Susan L Gottshall Selected Research

1- (2,3- dichlorobenzoyl)- 5- methoxy- 2- methyl- (2- (mopholin- 4- yl)ethyl)- 1H- indole

12/2005A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
4/2005Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Susan L Gottshall Research Topics

Disease

3Pain (Aches)
12/2005 - 04/2005
2Ataxia (Dyssynergia)
12/2005 - 04/2005
2Catalepsy
12/2005 - 04/2005
2Chronic Pain
12/2005 - 04/2005
1Hyperalgesia
04/2005
1Inflammation (Inflammations)
04/2005
1Necrosis
04/2005
1Osteophyte
04/2005

Drug/Important Bio-Agent (IBA)

2Cannabinoid Receptors (Cannabinoid Receptor)IBA
12/2005 - 04/2005
21- (2,3- dichlorobenzoyl)- 5- methoxy- 2- methyl- (2- (mopholin- 4- yl)ethyl)- 1H- indoleIBA
12/2005 - 04/2005
2CB2 Cannabinoid ReceptorIBA
12/2005 - 04/2005
1CannabinoidsIBA
12/2005
1Analgesics (Analgesic Drugs)IBA
12/2005
1Cannabinoid Receptor AgonistsIBA
04/2005
1PapainIBA
04/2005

Therapy/Procedure

1Analgesia
04/2005